2019-10-06 18:15:40


Hot Issue





send twitter 페이스북으로 보내기 Send to Me2 send to yuzum 싸이월드 공감
Zoom up Zoom Out Scrap E mail Print
Date [ 2014-04-24, 07:33 ]

New technology makes self-care treatment plausible.


(Kuala Lumpur=Koreanpress) AzmiAnuar =The global injectable drug delivery device technologies market was valued at approximately US D10.2bn in 2012 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 11% to USD17.2bn by 2017.

This comes as no surprise as the North American and European markets have adapted quickly to new technologies driven in part by the move away from hospital-based treatments towards home-based solutions. In other words, sick or unwell people can now administer treatment by themselves in the confines of their own homes.

While North America and Europe account for the lion’s share of these numbers with a similar CAGR rate of 12%, the Asia Pacific region is the leader in growth potential with an estimated CAGR rate of 18.5% from 2012 to 2017.

The growing demand in the Asia Pacific region, however, is driven by various factors such as a steady increase in number of collaborations between local and international biopharmaceutical companies, that tailor solutions to address the market's newly emerged needs. Generic injectables and biosimilars in particular are being looked at closely by several companies in the region.

In additional to factors that drive regional growth, auto-immune diseases as a whole are one of the biggest drivers for the need of devices like auto injectors due to the introduction of injectable biologics and improved patient compliance through self-injection mechanisms. With Korea an important player in the Asia Pacific region, Scandinavian Health Ltd(SHL) has been active in seeking out potential partnership opportunities. It already has manufacturing plants in the US and Taiwan.

As part of a continuous effort to engage with industry experts and partners, SHL was at the Primary Packaging and Drug Delivery Trends for Injectable Workshop in Seoul, Korea.

Marketing director Steven Kaufman presented on the topic of 'Insight into the Changing World of Auto Injectors’ on April 11, 2014.
Commenting on the upcoming participation, Kaufman said: "Even though SHL has often been referred to as one of the leaders in this market, we believe that it is actually the collaborations that we establish with the biopharmaceutical companies themselves that will ultimately drive the success of any project.
"It is more than just about design or innovation, but also integration and putting together the pieces of the puzzle with the help of our partners.

We are fortunate to have the opportunity to present at this workshop and connect with various local companies to see how we can further improve our products and services. "
In addition to speaking at this event and holding several private meetings, SHL will have a tabletop display exhibit at the workshop where the latest devices and materials will be available upon request in Korean and English.


Copyright(c) by Koreanpress All Rights Reserved. selva Other news
[Related News]
- No related news.
send twitter 페이스북으로 보내기 Send to Me2 send to yuzum 싸이월드 공감
Zoom up Zoom out Scrap E mail Print
Content Empathy
- No written comments.
The Last Economic Quarter of 2013 (2014-04-29 06:17:36)
The Other Economic Corridors (2014-04-01 12:47:11)